Effective July 1, 2018
Dear Prescription Data Submitter,
All system users must apply individually. This includes healthcare providers, pharmacists, and their staff applying as delegates. Access is granted to individuals only—not to clinics, hospitals, pharmacies or any other health care facility. For additional information, please see the PDMP User Guide. Please Read: Liability Statement. Common questions about the Prescription Monitoring Program (PMP) and Massachusetts Prescription Awareness Tool (MassPAT). PMP AWARXE will not confirm the existence of an account. If the user does not receive an email to the email address provided, the below steps should be followed. If the email address is a working email address but no.
The PMP Clearinghouse has been updated to the ASAP version 4.2A. This update includes the functionality to capture exemption codes for opioid prescriptions exceeding 100 morphine milligram equivalents, and the ICD-10 codes for the palliative care exemption.
The updated user guide outlining the ASAP 4.2A specifications, as well as a guide that crosswalks the Maine exemption codes to the ASAP 4.2A Treatment Codes is available on the Maine PMP website and is available in the Quick Links section of your PMP dashboard.
IMPORTANT CHANGES TO NOTE:
Massachusetts Pmp Awarxe User Support Manual
• DSP05 – Date Filled
This field should reflect the date the prescription left the pharmacy. This is to ensure that the patient report accurately reflects the date the patient received the prescription.
• DSP24 – Treatment Type
Required for opioid prescriptions exceeding 100 MME (see attached guide/crosswalk)
• DSP25 – Diagnosis Code
Required when Palliative Care Exemption Code is utilized for opioid prescriptions exceeding 100 MME
Pmp Awarxe Registration
You may begin reporting in ASAP 4.2A now, as the system will be accepting both ASAP 4.2 and ASAP 4.2A.
Effective July 1, 2018, the system will only accept ASAP 4.2A. (14-118 C.M.R. ch. 11, §5(C, 1, n.))
For additional information, please contact the PMP Team at SAMHS.PMP@maine.gov or by phone at (207) 287-2595 option 2.
For technical assistance, please contact the Appriss Clearinghouse helpdesk at (844) 463-4767
Thank you for your continued help preventing prescription drug misuse, abuse and diversion.
Sincerely,
The Prescription Monitoring Program Team
June 1, 2018:Data Submission Dispenser Guide (PDF)
You may access the Maine PMP at https://maine.pmpaware.net/login. |
PMP Contact: The Maine PMP AWARxE User Support Manual includes guidance for running patient and prescriber reports in the PMP system. For further technical assistance with logging in or running reports, you can contact the Appriss help desk at 1-844-4ME-4PMP (1-844-463-4767). |
Program Overview
The Prescription Monitoring Program (PMP) is a secure online database that is used across the State of Maine to improve public health. All prescribers and dispensers are able to review their patient's controlled substance drug history prior to prescribing or dispensing any schedule II – IV drugs. All prescribers and dispensers are able to be connected to this centralized system. The PMP helps to prevent adverse drug-related events through opioid overdoses, drug diversion, and substance abuse by decreasing the amount and/or frequency of opioid prescribing.
Documents in PDF format require the free Adobe Acrobat Reader to view them.
